Repligen (RGEN) Total Debt Growth (1y) (2014 - 2026)
Repligen (RGEN) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -13.10% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.92% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -1.34% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 0.15% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -35.01% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -4.84% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -0.41% |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 10,621.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,621.19% |
| Mar 31, 2026 | 1,529.44% |
| Dec 31, 2025 | 0.84% |
| Sep 30, 2025 | 3,796.63% |
| Jun 30, 2025 | -62.92% |
| Mar 31, 2025 | 39.06% |
| Dec 31, 2024 | 4,080.03% |
| Sep 30, 2024 | 10.70% |
| Jun 30, 2024 | -14.83% |
| Mar 31, 2024 | -12.51% |
| Dec 31, 2023 | -6.93% |
| Sep 30, 2023 | -6.69% |
| Jun 30, 2023 | -4.01% |
| Mar 31, 2023 | 0.16% |
| Dec 31, 2017 | 1,522.00% |
| Dec 31, 2016 | 36.58% |
| Sep 30, 2016 | 40.57% |
| Jun 30, 2016 | 35.95% |
| Mar 31, 2016 | 19.83% |
| Dec 31, 2015 | 294.71% |